Title
Vascular effects of diphenylmethoxypiperidine-derived dopamine uptake inhibitors
Document Type
Article
Date of Publication
6-1-2014
Publication Title
Bioorganic & Medicinal Chemistry Letters
First Page
2429
Last Page
2432
Abstract
Abstract
Vascular effects of 4-aryl methoxypiperidinol compounds previously shown to share with cocaine the ability to inhibit the dopamine transporter are described. All the compounds tested inhibit KCl-induced and noradrenaline-dependent contractions in mesenteric arteries ex vivo. Thus, diphenylpyraline and its analogs may have a role as therapeutic options for the treatment of some of the cardiotoxic effects of cocaine intoxications.
Graphical abstract
Studies of the in vitro vascular properties of 4-(arylmethoxy)-1-alkylpiperidine inhibitors of the dopamine transporter are reported. The lipophilicity given by the size of the N-aryl substituent potentiated the inhibitory effect with 4a being the most effective blocker of KCl and noradrenaline-induced contractions.
DOI
https://doi.org/10.1016/j.bmcl.2014.04.040
Recommended Citation
Pulgar, V. M. and Harp, J. K., "Vascular effects of diphenylmethoxypiperidine-derived dopamine uptake inhibitors" (2014). Pharmaceutical Sciences. 2181.
https://cufind.campbell.edu/pharmacy/2181